Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-06

FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for fluconazole from Rising Pharma Holdings, Inc., related to this generic antifungal product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)

Snippet

SUPPL AP for FLUCONAZOLE (FLUCONAZOLE)